Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Fahn

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
Parkinsonism & Related Disorders|March 11, 2018
Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohortRyul Kim, Joongyub Lee, Yoon Kim, et al.
Annals of Neurology|September 27, 2014
Mendelian randomization of serum urate and parkinson disease progressionKelly Claire Simon, Shirley Eberly, Xiang Gao, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2021
Neuropathological Findings in a Case of Parkinsonism and Developmental Delay Associated with a Monoallelic Variant in PLXNA1Sarah A O'Shea, Richard A Hickman, Etty Cortes, et al.
Parkinsonism & Related Disorders|September 24, 2013
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's diseaseRajesh Pahwa, Kelly E Lyons, Robert A Hauser, et al.
Movement Disorders Clinical Practice|May 22, 2018
Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102Stuart H Isaacson, Stanley Fahn, Rajesh Pahwa, et al.
Parkinsonism & Related Disorders|August 22, 2020
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment toolRoongroj Bhidayasiri, John M Kane, Karen P Frei, et al.
The Lancet. Neurology|November 27, 2019
Essential tremor-plus: a controversial new conceptElan D Louis, Martin Bares, Julian Benito-Leon, et al.
Movement Disorders Clinical Practice|August 18, 2021
Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by <i>MAPT</i> VariantsLaura Williams, Diana A Olszewska, Conor Fearon, et al.
Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.
The Lancet. Neurology|January 12, 2010
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisChris C Tang, Kathleen L Poston, Thomas Eckert, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
Parkinsonism & Related Disorders|March 11, 2018
Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohortRyul Kim, Joongyub Lee, Yoon Kim, et al.
Annals of Neurology|September 27, 2014
Mendelian randomization of serum urate and parkinson disease progressionKelly Claire Simon, Shirley Eberly, Xiang Gao, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2021
Neuropathological Findings in a Case of Parkinsonism and Developmental Delay Associated with a Monoallelic Variant in PLXNA1Sarah A O'Shea, Richard A Hickman, Etty Cortes, et al.
Parkinsonism & Related Disorders|September 24, 2013
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's diseaseRajesh Pahwa, Kelly E Lyons, Robert A Hauser, et al.
Movement Disorders Clinical Practice|May 22, 2018
Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102Stuart H Isaacson, Stanley Fahn, Rajesh Pahwa, et al.
Parkinsonism & Related Disorders|August 22, 2020
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment toolRoongroj Bhidayasiri, John M Kane, Karen P Frei, et al.
The Lancet. Neurology|November 27, 2019
Essential tremor-plus: a controversial new conceptElan D Louis, Martin Bares, Julian Benito-Leon, et al.
Movement Disorders Clinical Practice|August 18, 2021
Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by <i>MAPT</i> VariantsLaura Williams, Diana A Olszewska, Conor Fearon, et al.
Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.
The Lancet. Neurology|January 12, 2010
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisChris C Tang, Kathleen L Poston, Thomas Eckert, et al.
Pageof 17